Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2011, Vol. 12 Issue (10): 805-811    DOI: 10.1631/jzus.B1000422
    
Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma
Jian-zhong Di, Xiao-dong Han, Wen-ye Gu, Yu Wang, Qi Zheng, Pin Zhang, Hui-min Wu, Zhong-zheng Zhu
Department of General Surgery, the Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, China, Department of Gastroenterology, Shanghai Guanghua Hospital, Shanghai 200052, China, Department of General Surgery, Tongji Hospital, Tongji University, Shanghai 200065, China, Department of Oncology, No. 113 Hospital of People's Liberation Army, Ningbo 315040, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Global DNA hypomethylation has been associated with increased risk for cancers of the colorectum, bladder, breast, head and neck, and testicular germ cells. The aim of this study was to examine whether global hypomethylation in blood leukocyte DNA is associated with the risk of hepatocellular carcinoma (HCC). A total of 315 HCC cases and 356 age-, sex- and HBsAg status-matched controls were included. Global methylation in blood leukocyte DNA was estimated by analyzing long interspersed element-1 (LINE-1) repeats using bisulfite-polymerase chain reaction (PCR) and pyrosequencing. We observed that the median methylation level in HCC cases (percentage of 5-methylcytosine (5mC)=77.7%) was significantly lower than that in controls (79.5% 5mC) (P=0.004, Wilcoxon rank-sum test). The odds ratios (ORs) of HCC for individuals in the third, second, and first (lowest) quartiles of LINE-1 methylation were 1.1 (95% confidence interval (CI) 0.7–1.8), 1.4 (95% CI 0.8–2.2), and 2.6 (95% CI 1.7–4.1) (P for trend <0.001), respectively, compared to individuals in the fourth (highest) quartile. A 1.9-fold (95% CI 1.4–2.6) increased risk of HCC was observed among individuals with LINE-1 methylation below the median compared to individuals with higher (>median) LINE-1 methylation. Our results demonstrate for the first time that individuals with global hypomethylation measured in LINE-1 repeats in blood leukocyte DNA have an increased risk for HCC. Our data provide the evidence that global hypomethylation detected in the easily obtainable DNA source of blood leukocytes may help identify individuals at risk of HCC.

Key wordsCancer risk      Epigenetics      Global hypomethylation      Hepatocellular carcinoma      LINE-1 repetitive element     
Received: 05 December 2010      Published: 08 October 2011
CLC:  R735.7  
Cite this article:

Jian-zhong Di, Xiao-dong Han, Wen-ye Gu, Yu Wang, Qi Zheng, Pin Zhang, Hui-min Wu, Zhong-zheng Zhu. Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2011, 12(10): 805-811.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B1000422     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2011/V12/I10/805

[1] Zhong-dong Wang, Fan-yong Qu, Yuan-yuan Chen, Zhang-shen Ran, Hai-yan Liu, Hai-dong Zhang. Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(1): 27-36.
[2] Chong Lai, Ren-an Jin, Xiao Liang, Xiu-jun Cai. Comparison of laparoscopic hepatectomy, percutaneous radiofrequency ablation and open hepatectomy in the treatment of small hepatocellular carcinoma[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(3): 236-246.
[3] Ai-bin Zhang, Yi-gang Qian, Shu-sen Zheng. Prognostic significance of regulatory T lymphocytes in patients with hepatocellular carcinoma[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(12): 984-991.
[4] Yi-lei Zhao, Qing-qu Guo, Gen-ren Yang, Qi-dong Wang. Early changes in apparent diffusion coefficient as an indicator of response to sorafenib in hepatocellular carcinoma[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(8): 713-719.
[5] Yong-fang JIANG, Jing MA, Yan HE, Yong-hong ZHANG, Yun XU, Guo-zhong GONG. Cationic liposome-mediated transfection of CD40 ligand gene inhibits hepatic tumor growth of hepatocellular carcinoma in mice[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2009, 10(1): 7-13.
[6] WU Xiao-mo, FU Jing-geng, GE Wang-zhong, ZHU Jiang-yan, WANG Jun-yong, ZHANG Wei, QIAN Wei, HUO Ke-ke. Screen p53 mutations in hepatocellular carcinoma by FASAY: A novel splicing mutation[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2007, 8(2): 81-87.
[7] PAN Xiu-cheng, CHEN Zhi, CHEN Feng, CHEN Xiao-hong, JIN Han-yin, XU Xiao-yan. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2006, 7(10): 8-.